Gene · 4688
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lipopolysaccharide Stimulates A549 Cell Migration through p-Tyr 42 RhoA and Phospholipase D1 Activity. | Biomolecules | 2023 | 38275747 | PubTator, text mining | PubMed |
| Myeloid cell MHC I expression drives CD8+ T cell activation in nonalcoholic steatohepatitis. | Front Immunol | 2023 | 38274832 | PubTator, text mining | PubMed |
| Ferroptosis and metabolic syndrome and complications: association, mechanism, and translational applications. | Front Endocrinol (Lausanne) | 2023 | 38260171 | PubTator, text mining | PubMed |
| Central Role of β-1,4-GalT-V in Cancer Signaling, Inflammation, and Other Disease-Centric Pathways. | Int J Mol Sci | 2023 | 38203654 | PubTator, text mining | PubMed |
| Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice. | bioRxiv | 2023 | 38187647 | PubTator, text mining | PubMed |
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Case Report: The leopard sign as a potential characteristic of chronic granulomatous disease-associated colitis, unrelated to colitis severity. | Front Immunol | 2023 | 38152406 | PubTator, text mining | PubMed |
| Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis. | Int J Mol Sci | 2023 | 38139427 | PubTator, text mining | PubMed |
| Anti-Osteoarthritis Mechanism of the Nrf2 Signaling Pathway. | Biomedicines | 2023 | 38137397 | PubTator, text mining | PubMed |
| Dose-response effect of L-citrulline on skeletal muscle damage after acute eccentric exercise: an in vivo study in mice. | PeerJ | 2023 | 38130917 | PubTator, text mining | PubMed |
| Duplication of Exons 8-9 in NCF2 Leading to Incomplete Clinical Penetrance in Chronic Granulomatous Disease. | J Clin Immunol | 2023 | 38129542 | PubTator, text mining | PubMed |
| Integrative transcriptome and single-cell sequencing technology analysis of the potential therapeutic benefits of oleanolic acid in liver injury and liver cancer. | Aging (Albany NY) | 2023 | 38127054 | PubTator, text mining | PubMed |
| The multi-faceted role of NADPH in regulating inflammation in activated myeloid cells. | Front Immunol | 2023 | 38106413 | PubTator, text mining | PubMed |
| Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer. | Aging (Albany NY) | 2023 | 38095640 | PubTator, text mining | PubMed |
| Case report: Neonatal-onset inflammatory bowel disease due to novel compound heterozygous mutations in DUOX2. | Front Genet | 2023 | 38075699 | PubTator, text mining | PubMed |
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 | 38067234 | PubTator, text mining | PubMed |
| Qualitative Proteome-wide Lysine Crotonylation Profiling Reveals Protein Modification Alteration in the Leukocyte Extravasation Pathway in Systemic Lupus Erythematosus. | ACS Omega | 2023 | 38046296 | PubTator, text mining | PubMed |
| Proteomic analysis reveals changes in the proteome of human THP-1 macrophages infected with Paracoccidioides brasiliensis. | Front Cell Infect Microbiol | 2023 | 38045758 | PubTator, text mining | PubMed |
| Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions. | Cell Biosci | 2023 | 38041134 | PubTator, text mining | PubMed |
| Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. | J Clin Invest | 2023 | 38038136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4688/papers?page=7